Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Bioniche Animal Health

English French

Virtual Tour

Take a Virtual Tour of the Company's Vaccine Manufacturing Centre in Belleville, Ontario, Canada

In the News

April 14, 2014
Bioniche Life Sciences Inc. Shareholders Approve Sale of Animal Health Business


Other News

April 3, 2014
ISS Recommends that Bioniche Shareholders Vote in Favour of Animal Health Sale Transaction

Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a leading clinical stage biotechnology company focused on the development, manufacturing, and commercialization of proprietary and innovative therapeutics for the global human health market. The Company’s anchor product is in Phase III clinical development to treat non-muscle-invasive bladder cancer.
 
The Company is publicly traded on the Toronto Stock Exchange (TSX: BNC).

Proposed Animal Health Sale Transaction

Click here for more information.

 

 

Website by: SNAP 360

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy



Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video